 Abstract antimicrobial resistance, AMR, is a silent pandemic that threatens the efficacy of antibiotics and other antimicrobials. It is important to consider the ethical implications of how these resources are used and distributed, such as equitable access, responsible stewardship, environmental impact, and the development and promotion of these drugs. Additionally, the globalization of AMR and the involvement of multiple stakeholders must be taken into consideration. Opportunities for antimicrobial stewardship programs to optimize antibiotic use and reduce the emergence and spread of resistant bacteria should be explored. Furthermore, the environmental consequences of antibiotic use and the ethical implications of these impacts must be addressed. Finally, the pharmaceutical industry's role in the development and promotion of these drugs, as well as any potential conflicts of interest, must be considered. In conclusion, it is essential to preserve antibiotic efficacy for future generations by taking into account the ethical implications of AMR.